Literature DB >> 19072985

SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed?

Pierre Russo1, Jaclyn A Biegel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19072985      PMCID： PMC3094586          DOI： 10.1002/pbc.21893

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  22 in total

1.  Renal cell carcinoma with rhabdoid features: an aggressive neoplasm.

Authors:  K Kuroiwa; Y Kinoshita; H Shiratsuchi; Y Oshiro; S Tamiya; Y Oda; S Naito; M Tsuneyoshi
Journal:  Histopathology       Date:  2002-12       Impact factor: 5.087

Review 2.  The SWI/SNF complex--chromatin and cancer.

Authors:  Charles W M Roberts; Stuart H Orkin
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

3.  Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma.

Authors:  Y Oda; K Miyajima; K Kawaguchi ; S Tamiya; Y Oshiro; Y Hachitanda; M Oya; Y Iwamoto; M Tsuneyoshi
Journal:  Am J Surg Pathol       Date:  2001-08       Impact factor: 6.394

Review 4.  Hepatic tumors in children.

Authors:  J T Stocker
Journal:  Clin Liver Dis       Date:  2001-02       Impact factor: 6.126

Review 5.  Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.

Authors:  Yoshinao Oda; Masazumi Tsuneyoshi
Journal:  Pathol Int       Date:  2006-06       Impact factor: 2.534

6.  Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors.

Authors:  Andrew C Hoot; Pierre Russo; Alexander R Judkins; Elizabeth J Perlman; Jaclyn A Biegel
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

7.  Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.

Authors:  Alexander R Judkins; Joanne Mauger; As Ht; Lucy B Rorke; Jaclyn A Biegel
Journal:  Am J Surg Pathol       Date:  2004-05       Impact factor: 6.394

Review 8.  Where do we stand with hepatoblastoma? A review.

Authors:  J Marco Schnater; S Eleonore Köhler; Wouter H Lamers; Dietrich von Schweinitz; Daniël C Aronson
Journal:  Cancer       Date:  2003-08-15       Impact factor: 6.860

9.  Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior.

Authors:  Jason X Cheng; Maria Tretiakova; Can Gong; Saptarshi Mandal; Thomas Krausz; Jerome B Taxy
Journal:  Mod Pathol       Date:  2008-03-07       Impact factor: 7.842

10.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962
View more
  4 in total

1.  SNF5 as a prognostic factor in skull base chordoma.

Authors:  Mingxuan Li; Yixuan Zhai; Jiwei Bai; Shuai Wang; Hua Gao; Chuzhong Li; Songbai Gui; Jiang Du; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2017-12-08       Impact factor: 4.130

Review 2.  International pediatric liver cancer pathological classification: current trend.

Authors:  Yukichi Tanaka; Takeshi Inoue; Hiroshi Horie
Journal:  Int J Clin Oncol       Date:  2013-10-18       Impact factor: 3.402

3.  Imaging features of spinal atypical teratoid rhabdoid tumors in children.

Authors:  Hui-Ying Wu; Wen-Biao Xu; Lian-Wei Lu; He-Hong Li; Jin-Sheng Tian; Jian-Ming Li; Zheng-Rong Chen
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

Review 4.  A Systematic Review and Meta-Analysis of Malignant Rhabdoid and Small Cell Undifferentiated Liver Tumors: A Rational for a Uniform Classification.

Authors:  Juri Fuchs; Anastasia Murtha-Lemekhova; Markus Kessler; Fabian Ruping; Patrick Günther; Alexander Fichtner; Dominik Sturm; Katrin Hoffmann
Journal:  Cancers (Basel)       Date:  2022-01-06       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.